|
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
"22f dry seal was inserted prior to relay pro delivery.The relay pro device was delivered to the intended segment of the aorta.In step 1 we unsheathed the device.We turned it to step 2; dr (b)(6) started to turn the gray handle and felt strong resistance in the handle.I confirmed that he was turning the handle in the correct position.He said there was too much resistance (dr (b)(6) has deployed over 50 relay pros and knows the appropriate effort required).We pulled the device out of the body with no attempt to recapture it into step 1, since we were pulling it out through a dry seal sheath, so no injury was done to the vessels." patient outcome: "none.".
|